Release Date: 23/08/11 16:12 Summary: App4E, Chairman's Report and 30 June 11 Financial Statements Price Sensitive: Yes Download Document 1.16MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%